Safety considerations in elderly patients with metastatic colorectal cancer (mCRC) treated with bevacizumab-containing regimens: Important information for oncology nurses from the BRiTE study

被引：0
|
作者：
Senko, Alice [1 ]
Samuelson, E. [1 ]
Gowland, P. [2 ]
Merriman, N. [3 ]
机构：
[1] Genetech Inc, San Francisco, CA USA
[2] Ingalls Hosp, Harvey, IL USA
[3] Mark H Zangmeister Ctr, Columbus, OH USA
来源：
ONCOLOGY NURSING FORUM | 2008年 / 35卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2760
引用
收藏
页码：506 / 506
页数：1
相关论文
共 50 条
  • [1] BEVACIZUMAB-CONTAINING CHEMOTHERAPY IN ELDERLY PATIENTS WITH METASTATIC COLORECTAL CANCER
    Jernej, Benedik
    Marko, Boc
    Zvezdana, Hlebanja
    Neva, Volk
    Martina, Rebersek
    Janja, Ocvirk
    Tanja, Mesti
    ANNALS OF ONCOLOGY, 2014, 25
  • [2] Safety and effectiveness of bevacizumab (BV) and chemotherapy (CT) in elderly patients with metastatic colorectal cancer (MCRC): Results from the BRiTE observational cohort study
    Kozloff, M.
    Sugrue, M.
    Chiruvolu, P.
    Purdie, D.
    Berlin, J.
    Flynn, P.
    Kabbinavar, F.
    Sargent, D.
    Dong, W.
    Grothey, A.
    ANNALS OF ONCOLOGY, 2008, 19 : 26 - 26
  • [3] Safety and effectiveness of bevacizumab (BV) and chemotherapy (CT) in elderly patients (pts) with metastatic colorectal cancer (mCRC): Results from the BRiTE observational cohort study
    Kozloff, M. F.
    Sugrue, M. M.
    Purdie, D. M.
    Berlin, J. D.
    Flynn, P. J.
    Kabbinavar, F. F.
    Sargent, D. J.
    Dong, W.
    Grothey, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [4] Clinical Outcomes Associated with Bevacizumab-Containing Treatment of Metastatic Colorectal Cancer: The BRiTE Observational Cohort Study
    Kozloff, Mark
    Yood, Marianne Ulcickas
    Berlin, Jordan
    Flynn, Patrick J.
    Kabbinavar, Fairooz F.
    Purdie, David M.
    Ashby, Mark A.
    Dong, Wei
    Sugrue, Mary M.
    Grothey, Axel
    ONCOLOGIST, 2009, 14 (09): : 862 - 870
  • [5] Hypertension and overall survival in metastatic colorectal cancer patients treated with bevacizumab-containing chemotherapy
    Oesterlund, P.
    Soveri, L. -M
    Isoniemi, H.
    Poussa, T.
    Alanko, T.
    Bono, P.
    BRITISH JOURNAL OF CANCER, 2011, 104 (04) : 599 - 604
  • [6] Hypertension and overall survival in metastatic colorectal cancer patients treated with bevacizumab-containing chemotherapy
    P Österlund
    L-M Soveri
    H Isoniemi
    T Poussa
    T Alanko
    P Bono
    British Journal of Cancer, 2011, 104 : 599 - 604
  • [7] Effect and safety of bevacizumab-containing chemotherapy treatment in Chinese patients with metastatic colorectal cancer
    Wu, Qian
    Shi, Yan
    Chen, Li
    Xiao, Xiaoyi
    Dai, Guanghai
    ONCOTARGETS AND THERAPY, 2013, 6 : 485 - 490
  • [8] Safety of capecitabine plus bevacizumab in heavily treated patients with metastatic colorectal cancer (MCRC)
    Adamo, Vincenzo
    Festa, Vincenzo
    Restuccia, Eleonora
    Chiofalo, Giuseppe
    Maisano, Carmelo
    Picciotto, Maria
    Alafaci, Elisabetta
    Tortora, Giampaolo
    ANNALS OF ONCOLOGY, 2007, 18 : 16 - 17
  • [9] UTILIZATION OF CT SCAN AMONG METASTATIC COLORECTAL CANCER (MCRC) PATIENTS RECIVING BEVACIZUMAB CONTAINING REGIMENS
    Zheng, H.
    Barzi, A.
    McCombs, J. S.
    VALUE IN HEALTH, 2020, 23 : S64 - S65
  • [10] Serious arterial thromboembolic events (sATE) in patients (pts) with metastatic colorectal cancer (mCRC) treated with bevacizumab (BV): Results from the BRiTE registry
    Sugrue, M. M.
    Yi, J.
    Purdie, D.
    Dong, W.
    Grothey, A.
    Kozloff, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345